Skip to content
OpenCapital
Get started

Charles River Laboratories CRL Current Portion of Long-Term Debt and Finance Lease Obligations

Current Portion of Long-Term Debt and Finance Lease Obligations at other companies

Bruker logo
BrukerBRKR
——

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%—
Operating margin13%-2.4pp
Net margin-4.6%—
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%—
Debt / equity1×+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's current portion of long-term debt and finance lease obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's current portion of long-term debt and finance lease obligations?
Charles River Laboratories (CRL) reported current portion of long-term debt and finance lease obligations of $8.29M in Q1 2026.
How has Charles River Laboratories's current portion of long-term debt and finance lease obligations changed year-over-year?
Charles River Laboratories's current portion of long-term debt and finance lease obligations increased by 138.9% year-over-year, from $3.47M to $8.29M.
What is the long-term trend for Charles River Laboratories's current portion of long-term debt and finance lease obligations?
Over 5 years (2020 to 2025), Charles River Laboratories's current portion of long-term debt and finance lease obligations has grown at a -41.7% compound annual growth rate (CAGR), from $50.21M to $3.39M.